• Provider of revolutionary quality assurance software to the commercial 3D printing industry under the PrintRite3D® brand
• Estimated addressable market is $1.4 billion, projected to exceed $3.9 billion by 2023
• Currently, there are 23 Sigma Lab installations across 19 different users located around the globe
• Evaluations are underway with Tier-1 OEM clients for potential production-level software integration
• Experienced management team with deep industry experience, supplemented by an industry leading scientific advisory board
• Robust patent strategy established to protect intellectual property with seven patents granted, 18 patents pending, and four patent applications pre-publication

Sigma Labs Inc. (NASDAQ: SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

For more information, visit the company’s website at www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

• InsuraGuest’s proprietary InsurTech software platform delivers a specialized guest protection policy to the vacation rental and hotel industries
• Multi-billion-dollar market opportunity is worldwide, with the European market more than double the size of the U.S. market
• Number of vacation rental users globally is expected to soar to 361 million, at a 38 percent CAGR over the next five years

Service-as-a-software (SaaS) company InsuraGuest Inc. delivers a specialized insurance policy that protects guests during their stay at hotels and vacation rental properties. Through its proprietary InsurTech software platform, InsuraGuest provides the first line of defense for clients, properties and guests in an industry that is expected to host more than 297 million total vacation rental users worldwide in 2019 (http://ibn.fm/c76VG).

The InsurTech software platform delivers guest protection, acting as the first line of defense against accidents and losses for both the guest and the hotel or vacation rental property. When vacation rentals and hotels purchase the InsuraGuest protection policy, the coverage extends to the property’s guests once they check in. InsuraGuest provides specific coverage for such things as accidental damage to rooms, lost or stolen items, medical expenses, death or dismemberment (http://ibn.fm/L8y6C).

InsuraGuest provides software can integrate with more than 70 hotel and vacation rental property management systems worldwide. InsuraGuest is being integrated with vacation rental property management systems like Hostfully Inc. out of San Francisco and their system Orbirental, which currently has approximately 2,500 properties onboarded.

InsuraGuest is also working to expand the scope of its InsurTech platform and insurance products to cover European Union member states and the United Kingdom, while expansion plans include entering Asia by mid-2020 (http://ibn.fm/BQ0fO). InsuraGuest has already signed a letter of intent with a licensed Master General Agent operating in these markets, which will allow the company to distribute its products and proprietary platform to the hotel and vacation rental markets in these regions.

According to InsuraGuest CEO Douglas Anderson, there were 2.8 billion hotel nights stayed in Europe, compared to approximately 1.1 billion in the U.S. in 2018. With distribution in Europe and the United States, InsuraGuest’s combined demographics will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

For more information, visit the company’s website at www.InsuraGuest.com

NOTE TO INVESTORS: The latest news and updates relating to InsuraGuest are available in the company’s newsroom at http://ibn.fm/InsuraGuest

• Xalles Holdings is a company dedicated to building on blockchain and other technologies for solutions in the e-commerce, payments and financial reconciliation arenas
• Xalles’ most recent financials report showed the company’s fifth consecutive revenue-producing quarter and expectations for future revenue and asset growth
• The company remains bullish on cryptocurrencies such as bitcoin amid the market’s ups and downs, with recent worldwide rising trends underscoring crypto’s and Xalles’ potential

The potential benefits of riding out crypto volatility were again on display in late October as Bitcoin suddenly surged over $500 in just five minutes, joined in the ride by other top-20 coins that simultaneously posted gains, with some of them seeing double-digit price increases (http://ibn.fm/tmRye). A larger indication of alt-coins’ persistence emerged in trends developing at a national level in South America and Asia.

Fintech holding company Xalles Holdings Inc. (OTC: XALL) is an experienced payment systems and solutions builder that has become a dedicated believer in the cryptocurrency market, celebrating the upsides of crypto’s free trade system despite risks inherent in Bitcoin’s volatility such as when the alt-coin standard bearer experienced a series of significant drops after rallying to August highs.

Xalles’ primary aim is to offer payment solutions to consumers and to respond to more complex needs within large businesses and government entities, supporting and accelerating financial services technology development. Its revenue stream is built on a diversity of market segments inclusive of companies with business models that set up some manner of payment or financial transaction toll gate (http://ibn.fm/b6BMv).

Worldwide volumes for non-cash transactions were analyzed by Capgemini’s and BNP Paribas’ World Payments Report last year to establish a forecast, leading to a prediction they would climb from 538.6 billion transactions during 2017 to more than 1 trillion in 2022 at a CAGR of 14 percent, mostly driven by developing markets at an estimated CAGR of 30 percent in Asia thanks to China’s adoption of QR code-based payments (http://ibn.fm/6y0Dg).

China created some shockwaves October 24 when its president stated the government should lead the world in blockchain innovation, taking into account that China’s urban populations have been steadily advancing during recent years toward a goal of becoming the world’s first completely cashless society by 2020 (http://ibn.fm/oVOPy).

The country’s vice-chairman of the China Center for International Economic Exchanges (CCIEE) followed with reported comments that China will pioneer the first-ever blockchain-based central digital currency (http://ibn.fm/STgEo). Such alt-coin efforts enjoy some controversy because they rely on a central, government-controlled system similar to existing fiat operations but with centrally managed digital technology tools.

At the same time, Argentina generated news when Bitcoin usage rose there as disgruntled citizens traded 14.15 million Argentine pesos (ARS) amid government efforts to cap the number of U.S. dollars a person can purchase within a month at $200, a 98 percent plunge from the prior $10,000 allotment (http://ibn.fm/PdLI7).

The central bank decision was a bid to protect the national bank’s reserves at a time when the peso has experienced annual inflation of over 50 percent, but Bitcoin commentators argued a familiar free market theme with statements such as social media account Rhythm’s post, “It’s not your money if you need permission to use it,” underscoring the move by many of the country’s citizens to boost cryptocurrency accounts.

Xalles’ subsidiary Xalles Financial Services recently announced its partnership with ATN Trading to offer cryptocurrency trading. Xalles also anticipates multiple cryptocurrency asset portfolio acquisitions. The company’s subsidiaries also offer or will offer marketing capabilities, investment management, a proprietary software platform for post-payment audits, and non-profit fundraising platforms in addition to the company’s payment management operations.

Xalles’ ability to leverage blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions positions it as a potential fintech market leader as cryptocurrencies continue to shore up their bases. The company recently reported its fifth consecutive revenue-producing quarter and expectations for future revenue growth, as well as asset value growth.

For more information, visit the company’s website at www.Xalles.com

NOTE TO INVESTORS: The latest news and updates relating to XALL are available in the company’s newsroom at http://ibn.fm/XALL

• POAI subsidiary Helomics announce sequencing of ovarian tumor cases from UPMC Magee collaboration, a critical step in strategic Cancer Quest 2020 initiative
• Data key to value in $48-billion precision-medicine industry
• Industry leaders such as POAI realize critical value in patient-specific, data-driven models

The field of drug development for cancer treatment involves costly and time-intensive research. As technology plays an ever-increasing role in driving medicine, researchers and clinicians are discovering the significant potential of patient-derived models in matching specific cancer types with their most effective treatments. These models, which harness the patients’ own cancer cells to best determine how to defeat them, have been shown to be “a valuable tool for the identification of new treatment targets” (http://ibn.fm/DBK3s). To prepare for this next major frontier of precision medicine, industry leaders realize the critical value in these patient-derived (PDx) models of cancer. While most competitors are just getting their feet wet in both developing these PDx models and generating data from them, Predictive Oncology Inc. (NASDAQ: POAI) has been swimming in the deep end for some time, boasting an immensely valuable historic database of drug response for patients from its own proprietary PDx tumor models.

In the precision-medicine industry, the value of any predictive model is directly related to the quality and quantity of data used to build it. The richer and more extensive a predictive model’s data set, the more accurate and generalizable the predictions become. This predictive value translates into tremendous dollar potential in the field of precision medicine, a $48 billion industry in 2018 (http://ibn.fm/F7n7L), and Predictive Oncology is well positioned in this regard. Through its partnership with UPMC Magee Women’s Hospital, POAI subsidiary Helomics has been able to analyze “the genomic and drug-response profiles of women with ovarian cancer to build AI-driven predictive model of response to therapy” (http://ibn.fm/YQKky). Recently, Helomics announced that it has begun sequencing the tumor cases from this collaboration, a critical step in its strategic Cancer Quest 2020 project (http://ibn.fm/F93kH) as POAI moves towards the goal of building out its extensive database of tumor drug-response data.

“These retrospective ovarian cancer cases were profiled [by] Helomics as early as 2010; hence, we have 10 years’ worth of drug-treatment data, survival and other outcome measures we are gathering from Magee’s clinical databases,” stated Helomics chief innovation officer Dr. Mark Collins. “We are now sequencing these cases, looking at both the tumor mutations (genome) as well as tumor-gene expression (transcriptome) to build a comprehensive multi-omic picture of the tumor. We are also using deep learning on histopathology images of the tumor tissue (tissue-omics) to add an additional dimension to this multi-omic profile. We believe the combination of the rich multi-omic profile of the tumor and clinical outcome data will allow us to build an AI-driven model of ovarian cancer capable of predicting the tumor drug response and patient outcome (prognosis).”

POAI’s platform, composed of over 150,000 patient tumors, harnesses the power of an individual patient’s tumor to help recommend the best treatment for that patient. This database, which houses evidence documenting actual drug responses of cancer patients’ individual tumors, uses artificial intelligence to create a valuable predictive tool for pharmaceutical companies and researchers.

Industry leaders believe that models utilizing patient-derived data powered by artificial intelligence will allow doctors to make more effective individualized treatment recommendations, changing the landscape of cancer treatment. The predictive models can be applied clinically for patients of today, and they can also be used in the development of new drugs by researchers to help cancer patients of tomorrow.

Predictive Oncology offers the potential for significant ROI as it focuses on improving patient outcomes, changing the status quo of cancer treatment.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• SHRG has generated $129 million in cumulative sales since its launch of own products; company revenue reached $35.4 million in Q1 2019, more than double sales from prior year
• ‘Blue Ocean Strategy’ is the unique and successful method for SHRG’s Elepreneur independent distributors to sell the company’s line of proprietary health and wellness products
• SHRG has global expansion plans to implement through 2019, according to John “JT” Thatch, CEO

Sharing Services Global Corporation (OTCQB: SHRG) has gained momentum in its record sales by employing its Blue Ocean Strategy, a unique and successful method of selling its proprietary product line through its Elepreneur independent distributors. Since the company’s own line of health and wellness products was introduced in December 2017, SHRG has reported cumulative sales of greater than $129 million. For Q1 2019, the three months ending July 31, Sharing Services reached revenues of $35.4 million, more than double that of the comparable period in 2018 (http://ibn.fm/YRX56).

The company’s deliberate approach stems from the book Blue Ocean Strategy by W. Chan Kim and Renée Mauborgne. The Blue Ocean Strategy is a systematic approach to selling that renders the competition irrelevant by creating and operating in an uncontested market space. The approach also calls for creating and capturing new demand, and strategy execution calls for exceeding expectations (http://ibn.fm/LswWJ).

The launch of SHRG’s proprietary line of health and wellness products in 2017 through its Elepreneurs LLC and Elevacity Global LLC subsidiaries marked a company milestone. The products all are based on the D.O.S.E. product formulation of four hormones designed to promote happiness and well-being (http://ibn.fm/c6477).

“Product sales for our incredible health and wellness products of Elevacity Global were strong from the beginning and have since dramatically and consistently increased,” SHRG CEO John “JT” Thatch stated in a news release (http://ibn.fm/xKj2j). The company has announced global expansion plans that it will continue to implement throughout 2019.

In a 10-K SEC filing, SHRG reported record sales of $85.9 million for its fiscal year ended April 30, 2019 (http://ibn.fm/PBGfz). This represents a nine-fold increase or $77.5 million jump from company revenues of $8.4 million the prior year.

“Our 2019 revenues are continued proof that our Blue Ocean Strategy is being implemented and accepted in the direct-selling marketplace,” Thatch added (http://ibn.fm/ihlxt). “We continue at a record-breaking pace as our dedicated and highly talented Elepreneurs continue to execute on the mission to change the direct selling industry with best-in-class products and services.”

Thatch noted that Elevacity Global has consistently increased its sales of health and wellness products. Since the product launch in late 2017, SHRG has supported expansion with several initiatives including establishing a new corporate headquarters to accommodate growth, bringing in experienced industry talent and pursuing global expansion plans.

In the 10-K filing, SHRG reported that since inception and for its FY ended April 30, 2019, some 97 percent of its consolidated net sales have been generated by the company’s health and wellness product line. Economies of scale and selective price increases helped SHRG raise its consolidated gross margin to 66.5 percent for its FY ended April 30, 2019, compared to 52.3 percent from the year earlier period.

SHRG is a Plano, Texas-based diversified holdings company that owns and operates companies engaged in direct selling through independent sales contractors as the sales force. The company also offers services such as energy, technology and insurance. Its divisions include Elevacity Global LLC and Elepreneur LLC.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• Wonderfilm Media is backed by four Hollywood producers with $1 billion worth of movie revenues between them
• Wonderfilm’s producing team is attending American Film Market to pre-sell intellectual properties for the company’s expanding slate of movies and television/streaming series and potentially solidify new projects
• With a $58 million total budget and 17 productions greenlit, Wonderfilm’s low-risk approach to content production results in predictable and consistent revenue streams

Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF), a publicly traded entertainment company, with offices in Los Angeles and Vancouver, has developed a risk-averse production process that provides forecastable and consistent revenues. This innovative approach assures that Wonderfilm productions are structured to start generating a return to the company as soon as the camera starts rolling.

Soaring demand for content from streaming providers is fueling industry growth with established media giants in an all-out sprint to dominate some very lucrative revenue streams, a Bloomberg article states (http://ibn.fm/k804y). One segment of this industry, the global video on demand market, was valued at $28.9 billion in 2017 and is expected to reach $89.3 billion by 2026 at a compound annual growth rate of 15.4 percent during the forecast period, according to a research report (http://ibn.fm/RzB15).

“The content creation opportunities in the market today are akin to a new gold rush. After 30 years in this business, I have never been more excited to be a movie and TV content producer,” Wonderfilm CEO Kirk Shaw, a prolific filmmaker with 230 films and seven TV shows to his credit, tweeted (http://ibn.fm/jldjq).

Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few. Some of the company’s most notable greenlit projects include the horror film ‘Amityville 1974’, slated for theatrical release in October 2020, and the action film ‘Inside Game’ starring Tyrese Gibson, which will be released to theaters in fall 2020.

Wonderfilm has discussed plans to launch its own streaming channel (http://ibn.fm/Lx4jQ), but for now the company is focused on creating films for other distributors, both cinematic and online. Once the company secures a script and signs an A-list star, Wonderfilm pre-sells the film before shooting starts. Whether the project is sold to a streaming service or a cinematic distributor, this approach eliminates distribution risks. Not only does this secure much of the finance needed to make a film happen, it also ensures that the project will reach its audience (http://ibn.fm/Hy2mA).

Wonderfilm’s combined producer team of Kirk Shaw, Shaun Redick, Yvette Yates, Dan Grodnik, Bret Saxon and Jeff Bowler, is attending this year’s American Film Market (“AFM”) in Santa Monica, California – a first for the company and a perfect opportunity to implement the company’s business strategy, Shaw stated in a news release

“Getting ready for the American Film Market in Santa Monica is a busy time of year for all of us,” Shaw stated in a news release. “Shaun, Yvette and Dan have been preparing their AFM game plans for several months, while Bret and Jeff have been equally busy lining up strategic meetings with potential new production and distribution partners. It’s exciting for the Team, as well, since this is the first AFM the entire group is attending together to implement interconnected strategies that target different aspects of the film and television market – including pre-selling movies. AFM almost never disappoints, so in the weeks and months ahead, we expect to be able to announce new Wonderfilm movies and series achieved directly from participation in AFM 2019.”

For more information, visit the company’s website at www.Wonderfilm.com

NOTE TO INVESTORS: The latest news and updates relating to WDRFF are available in the company’s newsroom at http://ibn.fm/WDRFF

• Achieving considerable progress in the research and development of new products utilizing its innovative cannabinoid delivery systems
• In the process of introducing several cannabinoid consumer products based on the company’s internally developed high bioavailability infusion technologies
• Highly experienced management team with significant participation in the cannabis and hemp industries
• IP portfolio includes four patents on the company’s cannabinoid delivery technology systems

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://ibn.fm/so6ug).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://ibn.fm/K3LKz):

• Significantly improving bioavailability
• Allowing for ultra-high loading rates
• Enhancing customization of cannabinoid combinations
• Improved dosing precision
• Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://ibn.fm/yPCj1). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

• The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
• Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
• Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
• Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

For more information, visit the company’s website at www.CannabisGlobalInc.com

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://ibn.fm/MCTC

• SRAX, a digital marketing and consumer data management technology company, has multiple recurring revenue streams through various platforms
• SRAX’s CEO Christopher Miglino to be joined by key members of SRAX leadership
• Operational and financial summary call to be webcast live, accessible at company’s website

Digital marketing and consumer data management technology company SRAX Inc.’s (NASDAQ: SRAX) Founder and CEO Christopher Miglino will host the company’s conference call on November 13 at 1:30 p.m. (PST). The call will detail the company’s Q3 2019 operational and financial summary. Joining Miglino on the call will be COO Kristoffer Nelson; CFO Mike Malone; Vice President of SRAX Shopper George Stella; and Vice President of Research Sales Rick McCrady (http://ibn.fm/1fu59).

SRAX is a digital marketing and consumer data management technology company. Through development of its BIGtoken platform, SRAX offers a secure and transparent environment for consumers to own and earn from their data (http://ibn.fm/6HVPF). Developed by SRAX, BIGtoken can be downloaded from both the App Store and Google Play. This platform boasts over 16 million BIGtoken registered users worldwide and provides consumers with a safe and transparent environment for monetization of their data (http://ibn.fm/2KrZT).

Through BIGtoken, SRAX has created a symbiotic relationship between big brands desiring to know their consumers better and the consumers themselves who want to remain in control of their data at ever-increasing rates. In exchange for giving brands access to their data by answering surveys, checking into locations, referring friends, and more, BIGtoken users are rewarded with points, which they can then redeem for cash and gift cards or make charitable donations. SRAX’s technology then unlocks data to reveal the core consumers of brands across marketing channels. As one of the first companies to offer consumers a significant piece of the data pie, SRAX is building the largest and most valuable opted-in data set in the world.

Additionally, while major social media giants like Facebook are backpedaling over mismanagement of users’ privacy, SRAX‘s platform takes care of the consent issue early on in the process. SRAX asks users for permission to share data when they initially sign up for the BIGtoken platform. The company is ahead of the competition in California, where a new privacy law compliance bill designed to protect consumers’ privacy goes into effect January 1, 2020. A report from CNBC noted that the legislation may cause firms to pay in aggregate up to $55 million in initial compliance costs, according to an assessment prepared by an independent research firm for the state attorney general’s office in California (http://ibn.fm/MeWdH).

SRAX’s machine learning technology analyzes marketing data, and its BIGtoken platform enables consumers to own, manage, and sell access to their digital identity and data. This provides SRAX with valuable proprietary data and multiple revenue streams (http://ibn.fm/OEPQu).

To register for the conference call, interested parties can visit http://ibn.fm/tRWDb. The call can be heard live at (877) 451-6152 if calling from the U.S. or Canada. For international participation, listeners should dial (201) 389-0879; the conference ID is 13695604. The call will also be available for at least 90 days on the company’s website.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at  http://ibn.fm/SRAX

• OriginClear 1-for-2000 reverse stock split designed to prepare company for future growth, acquisitions
• Announcement comes after OCLN posted positive financial numbers in SEC 10-K annual filing
• CEO confident that year-over-year improvements in existing businesses will continue

OriginClear Inc. (OTC: OCLND), an advanced player in the decentralized water revolution, has announced the implementation of a 1-for-2000 reverse stock split as part of a solid financial plan designed to strengthen capital structure for future growth and acquisitions (http://ibn.fm/4RCOF). OriginClear is well-positioned in the water treatment sector, which is anticipated by some to become a trillion-dollar industry by 2020. As water scarcity looms, noted as “one of the three global systemic risks of highest concern” by The World Economic Forum, increasing numbers of businesses are looking beyond municipalities for ways to take their location’s water-treatment into their own hands. OriginClear is ready to fill this void with its onsite, point-of-use water-treatment systems which it has been pioneering the last several years, and its reverse stock split is another achievement on its path to empowering companies around the world to achieve self-reliant water independence.

The company’s reverse stock split is anticipated to help maintain the company’s bid price listing requirements on the OTCQB Venture Exchange. Implemented on October 24, the stock split resulted in the number of OriginClear outstanding shares of common stock decreasing from an estimated 6.2 billion to about 3.2 million (http://ibn.fm/nInJi). Also, as a result of the reverse stock split, the company’s common stock ticker symbol will be OCLND for 20 trading days following the implementation.

“This reverse stock split is part of a plan to strengthen our capital structure for future growth and potential acquisitions,” Riggs Eckelberry, OriginClear CEO, stated in a news release.

This strategic move comes after the company posted positive financial numbers in its April SEC 10-K annual filing. In that filing, the company reported increased revenue with narrowing operating losses. Specifically, 2018 revenue increased by 38 percent to $4,637,698 over 2017, and gross profit increased by 78 percent to $1,153,680, while margins improved by six percent overall. Operating losses narrowed by $1,231,703 to $4,062,351, a 23 percent improvement over 2017 numbers.

“While there can be no guarantee that we will complete our prospective acquisitions, we are confident that the year-over-year improvements in our existing businesses will continue,” said Eckelberry.

As part of the reverse stock split, every 2,000 shares of OriginClear’s common stock outstanding will be reclassified into one new share of common stock, with no fractional shares issued in connection with the reverse stock split. The effect of the reverse stock split on existing OriginClear stockholders will be uniform across the board, with stockholders’ percentage ownership interests in the company remaining the same, except to the extent that the reverse stock split results in fractional shares. Any fractional share of common stock from the reverse stock split will be rounded up to the nearest whole share.

Additionally, all OCLN convertible notes, convertible preferred stock, stock options, other equity awards and warrants outstanding immediately prior to the reverse stock split will be proportionately adjusted.

OriginClear is a leading provider of water-treatment solutions. The company offers breakthrough water-treatment and conveyance products that effectively improve the quality of water by returning it to its original and clear condition. The company’s stated mission is to empower this global self-reliant water movement with its Modular Water Systems (TM) (http://ibn.fm/C1GX1), advanced water treatment and conveyance products that enable water independence and help make clean water available for all. OriginClear provides innovative water-treatment systems that not only assist companies in increasing their operating efficiency and asset value but also help those companies meet new environmental and social governance (ESG) standards.

For more information, visit the company’s website at www.OriginClear.com

NOTE TO INVESTORS: The latest news and updates relating to OCLN are available in the company’s newsroom at http://ibn.fm/OCLN

• Old media joins SVoD services in spending splurge on content
• Major film studios launch TV streaming services
• Recent report calls boom ($165 billion in 2018) a “golden age of spending”

The next blockbuster in the film-production world could be Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF). The company is set to benefit as subscription video on demand (SVoD) services and “old media” continue to splurge on content. Streaming services such as Amazon Prime, Hulu and Netflix are driving demand for video content from independent film producers. Not to be left behind, established studios are shopping for content too, further increasing demand. The competition between old and new media has resulted in a 65 percent increase in global content spending over the last decade. This is a trend that shows no signs of abating, which augurs well for Wonderfilm. The company is well positioned to significantly increase its existing $58 million annual production slate to meet new demand.

A recent report shows how SVoD has become an essential component of U.S. domestic felicity. “Nearly three fourths of American homes, 74 percent, subscribe to at least one of the major SVoD services, Netflix, Amazon Prime or Hulu, up from just 64 percent in 2017 and 52 percent in 2015,” the article noted (http://ibn.fm/ushg6). Established film studios have taken the cue. The five majors have all launched SVoD services or have links to such services. Most notably is Disney, whose Disney+ streaming service is set to debut on November 12 this year. Spending on content from the company that produced megahit ‘The Lion King’ reached $13 billion in 2018.

Warner Bros is also in (http://ibn.fm/Nov93). Its SVoD service “will debut in the U.S. in a beta form in the fourth quarter of 2019, with a full launch in Q1 2020.” So, too, is Universal Pictures, which plans to launch its SVoD service in 2020 (http://ibn.fm/Ca0ZC). Paramount Pictures’ parent company, Viacom, already has its Paramount+ streaming services, currently available in the Nordics and across Central and Eastern Europe (http://ibn.fm/0uI6x). Sony, which owns Columbia Pictures, already has its SVoD platform, Crackle, streaming content to more than 20 countries.

The global splurge on TV, film and sports content had increased to $165 billion in 2018, up from $100 billion in 2008, with most of that increase occurring in the last five years, according to a recent Ampere Analysis report (http://ibn.fm/XYdGO). While new media outfits such as Netflix have dug deep in their wallets to purchase content, a bulk of the expenditure – $111 billion of the $165 billion spent in 2018 – has come from old media. But a dollar is a dollar, regardless of who’s spending, and indie producers stand to benefit either way.

Wonderfilm, particularly, is in a position to benefit from this liberality. The company is backed by four Hollywood producers who have produced over $1 billion worth of hit movies. Forged from a coalition of strength, WNDR brings together several leading industry execs with well-established track records of individual success. Wonderfilm is using a new, wider business model that allows the company to quickly finance and produce film and television content for both foreign and domestic markets. The company works with some of Hollywood’s top talent to create unforgettable films while providing value for its shareholders.

Movies with which members of Wonderfilm’s producing team have been involved or associated include ‘Get Out’ (2017), which cost $4.5 million to make and grossed $255 million at the box office; ‘BlacKkKlansman’ (2018), which grossed $93 million on a budget of $15 million; and ‘National Lampoon’s Christmas Vacation’, which has grossed $71 million on a budget of $25 million. As of October 2019, Wonderfilm has 17 movies ready to be shot or green lit (not yet shot).

“The content creation opportunities in the market today are akin to a new gold rush,” Wonderfilm CEO Kirk Shaw stated in a news release (http://ibn.fm/SRgwI). “After thirty years in this business, I’ve have never been more excited to be a movie and TV content producer.”

No wonder the Ampere Analysis report has christened the boom a “golden age of spending.”

For more information, visit the company’s website at www.Wonderfilm.com

NOTE TO INVESTORS: The latest news and updates relating to WDRFF are available in the company’s newsroom at http://ibn.fm/WDRFF